{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-017427","form_type":"8-K","ticker":"BVS","cik":"0001665988","company_name":"Bioventus Inc.","filed_at":"2023-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.940694+00:00","generated_at":"2026-06-15T04:15:37.548343+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bioventus delays Q1 10-Q filing; prelim revenue ~$119M, Adj. EBITDA ~$17M","bullets":["Filing delayed due to complexity in tax structure and noncontrolling equity interest calculation.","Preliminary Q1 revenue ~$119M; Adjusted EBITDA ~$17M; no impact on revenue or EBITDA from the calculation.","Company expects to file Form 10-Q by May 16, 2023, and remain in compliance with all financial covenants.","Earnings call rescheduled to May 16, 2023 at 8:30 a.m. ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-017427","json":"https://secwatch.observer/filing/0001628280-23-017427.json","markdown":"https://secwatch.observer/filing/0001628280-23-017427.md","text":"https://secwatch.observer/filing/0001628280-23-017427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1665988/000162828023017427/0001628280-23-017427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1665988/000162828023017427/bvs-20230511.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T04:15:37.548343+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2953a8590f6eacf6e757fd7575e9dcb2b22b7c51","claim":"Bioventus Inc. reported the quarter ended April 1, 2023 results: revenue approximately $119 million.","evidence_excerpt":"At this time, the Company expects to report revenue for the quarter ended April 1, 2023, of approximately $119 million and Adjusted EBITDA of approximately $17 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1665988/000162828023017427/0001628280-23-017427-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended April 1, 2023"},{"label":"Revenue","value":"approximately $119 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}